CN103893634B - Traditional Chinese medicine for treating infantile cholestasis - Google Patents

Traditional Chinese medicine for treating infantile cholestasis Download PDF

Info

Publication number
CN103893634B
CN103893634B CN201410159431.2A CN201410159431A CN103893634B CN 103893634 B CN103893634 B CN 103893634B CN 201410159431 A CN201410159431 A CN 201410159431A CN 103893634 B CN103893634 B CN 103893634B
Authority
CN
China
Prior art keywords
parts
chinese medicine
cholestasis
effects
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410159431.2A
Other languages
Chinese (zh)
Other versions
CN103893634A (en
Inventor
冯向春
徐涛
国伟婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410159431.2A priority Critical patent/CN103893634B/en
Publication of CN103893634A publication Critical patent/CN103893634A/en
Application granted granted Critical
Publication of CN103893634B publication Critical patent/CN103893634B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the technical field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine for treating infantile cholestasis. The traditional Chinese medicine comprises the following components in parts by weight: 25-35 parts of oriental wormwood, 25-35 parts of rhizoma atractylodis nacrocephalae, 5-12 parts of peach kernels, 15-25 parts of lysimachia christinae hance, 16-25 parts of golden cypress, 14-26 parts of oldenlandia diffusa, 18-26 parts of semen litchi, 26-35 parts of raw malt, 0.5-1.5 parts of amber, 0.5-1.5 parts of indigo naturalis and 0.5-1.5 parts of resina draconis. In the formula, oriental wormwood which is a monarch drug has the effects of clearing heat, promoting diuresis and removing jaundice; lysimachia christinae hance, oldenlandia diffusa and golden cypress which are ministerial drugs assist oriental wormwood to enhance the effects of promoting diuresis and removing jaundice; peach kernels, semen litchi and resina draconis which are ministerial drugs assist oriental wormwood to enhance the effect of promoting blood circulation to remove blood stasis; amber and indigo naturalis which are guide drugs enter into the liver channel and have the effects of relieving convulsion and soothing the nerves; rhizoma atractylodis nacrocephalae and raw malt which are assistant drugs have the effects of invigorating spleen to promote digestion and restricting side effects of the above medicines. All the medicines are used together to take the effects of promoting blood circulation to remove blood stasis, promoting diuresis and removing jaundice. The traditional Chinese medicine decoction is good in compliance, small in dosage, fast in effect, free of toxic and side effects and high in curative effect rate.

Description

A kind of Chinese medicine treating baby's cholestasis
Technical field
The invention belongs to lunar physics technique field, particularly to a kind of Chinese medicine treating baby's cholestasis.
Background technology
Baby's Intrahepatic Cholestasis refer to that baby leads to normal bile flow to reduce because of certain reason, increase with bilirubin direct And cause a kind of syndrome being clinically main performance with jaundice, it is infantile common disease, treatment difficulty is big, be baby One of lethal, major reason of disabling.Baby's Intrahepatic Cholestasis cause of disease is complicated, its occur may with biliary tract inflammation, developmental disorder, The factors such as viral infection, dealed with medicine went, hereditary metabolic disorders and immunity are relevant, diagnosis and treatment not in time, often lead to seek Support bad, growth retardation, or even biliary cirrhosiss, have a strong impact on the life quality of infant, or even threat to life.Mesh Before, the method for the treatment of baby's cholestasis is less and curative effect is not affirmed, the no Therapeutic Method of specially good effect both at home and abroad.
Content of the invention
Pointed out according to above-mentioned deficiency, it is an object of the invention to provide a kind of prepare treatment baby's gallbladder simple, evident in efficacy The Chinese medicine of juice alluvial.
For achieving the above object, the technical scheme is that a kind of Chinese medicine treating baby's cholestasis, according to weight Number meter, it includes following component, Herba Artemisiae Scopariae 25-35 part, Rhizoma Atractylodis Macrocephalae 25-35 part, Semen Persicae 5-12 part, Herba Lysimachiae 15-25 part, Cortex Phellodendri 16-25 part, Herba Hedyotidis Diffusae 14-26 part, Semen Litchi 18-26 part, Fructus Hordei Germinatus 26-35 part, succinum 0.5-1.5 part, Indigo Naturaliss 0.5- 1.5 parts, Sanguis Draxonis 0.5-1.5 part.
Preferably: in parts by weight, it includes following component, Herba Artemisiae Scopariae 27-33 part, Rhizoma Atractylodis Macrocephalae 27-33 part, Semen Persicae 7- 10 parts, Herba Lysimachiae 17-23 part, Cortex Phellodendri 18-23 part, Herba Hedyotidis Diffusae 16-24 part, Semen Litchi 20-24 part, Fructus Hordei Germinatus 28-33 part, Succinum 0.7-1.3 part, Indigo Naturaliss 0.7-1.3 part, Sanguis Draxonis 0.7-1.3 part.
Preferably: in parts by weight, it includes following component, Herba Artemisiae Scopariae 29-31 part, Rhizoma Atractylodis Macrocephalae 29-31 part, Semen Persicae 8- 9 parts, Herba Lysimachiae 19-21 part, Cortex Phellodendri 20-21 part, Herba Hedyotidis Diffusae 18-22 part, Semen Litchi 21-23 part, Fructus Hordei Germinatus 30-31 part, Succinum 0.9-1.1 part, Indigo Naturaliss 0.9-1.1 part, Sanguis Draxonis 0.9-1.1 part.
Preferably: in parts by weight, it includes following component, 30 parts of Herba Artemisiae Scopariae, 30 parts of the Rhizoma Atractylodis Macrocephalae, 10 parts of Semen Persicae, gold 20 parts of money grass, 20 parts of Cortex Phellodendri, 20 parts of Herba Hedyotidis Diffusae, 20 parts of Semen Litchi, 30 parts of Fructus Hordei Germinatus, 1 part of succinum, 1 part of Indigo Naturaliss, Sanguis Draxonis 1 Part.
Preferably: described Chinese medicine is decoction.
The beneficial effects of the present invention is: the pharmaceutical characteristic of each activated feedstock is:
Herba Artemisiae Scopariae: clearing away heat-damp and promoting diuresis, jaundice eliminating subcutaneous ulcer.For cold-damp, jaundice due to damp-heat.
Herba Lysimachiae: relieving stranguria by diuresis, dehumidify jaundice eliminating, removing toxic substances and promoting subsidence of swelling.For diseases such as pyretic stranguria, sand Stranguria, stranguria caused by urinary stone, jaundice.
Cortex Phellodendri: heat clearing and damp drying, eliminating fire and detoxication.For diseases such as damp-heat dysentery, jaundice.
Herba Hedyotidis Diffusae: clearing away heat-damp and promoting diuresis, removing toxicity for eliminating carbuncles.For diseases such as carbuncle sore tumefacting virus, pyretic stranguria, dysuria.
Semen Persicae: blood circulation promoting and blood stasis dispelling.Disease for dysmenorrhea, stasis blocking pain.
Semen Litchi: regulating QI to relieve pain, cold relieving dissipates stagnant.For diseases such as the colic caused by Liver Channel QI stagnated by cold and qi depressions to blood stasis.
Sanguis Draxonis: promoting blood circulation to remove blood stasis, analgesic therapy, hemostasia and promoting granulation.For ecchymoma due to internal injury, the disease such as traumatic injury.
Succinum: tranquillizing the mind by relieving convulsion, promoting blood circulation to remove blood stasis, inducing diuresis for treating stranguria syndrome.For malaise, infantile convulsion epilepsy, stagnation of blood stasis disease, drench Disease, the disease such as difficulty in urination.
Indigo Naturaliss: heat-clearing and toxic substances removing, removing heat from blood dissipates swollen.This product is apt to clearing away liver-fire, sends out the disease of speckle, infantile convulsion for pyretic toxicity.
The Rhizoma Atractylodis Macrocephalae: air making-up and spleen enlivening, eliminate dampness and have diuretic effect.Disease for deficiency-weakness of spleen-QI.
Fructus Hordei Germinatus: help digestion and in, soothing the liver.For the disease of stagnation of QI due to depression of the liver, as adjuvant.
In formula, Herba Artemisiae Scopariae heat-clearing and dampness-resolving, is monarch.Herba Lysimachiae, Herba Hedyotidis Diffusae, Cortex Phellodendri auxiliary Herba Artemisiae Scopariae strengthen dampness removing and move back Yellow effect;Semen Persicae, Semen Litchi, Sanguis Draxonis auxiliary Herba Artemisiae Scopariae strengthen blood circulation promoting and blood stasis dispelling effect, are ministerial drug.Succinum, Indigo Naturaliss enter Liver Channel, shake Shy and calm the nerves, for making medicine.The Rhizoma Atractylodis Macrocephalae, Fructus Hordei Germinatus strengthening the spleen to promote digestion, restrict above side effects of pharmaceutical drugs, are adjuvant drug.All medicines share, and play and live Blood and dissolving stasis, the effect of removing dampness through diuresis and removing jaundice.The compliance of this Chinese medicine decoction is good, and consumption is few, instant effect, and has no toxic side effect, treated Efficiency high.
Specific embodiment
With reference to specific embodiment, the present invention will be further described.
Embodiment 1
A kind of Chinese medicine treating baby's cholestasis, in parts by weight, it includes following component, 25 parts of Herba Artemisiae Scopariae, in vain 25 parts of art, 5 parts of Semen Persicae, 15 parts of Herba Lysimachiae, 16 parts of Cortex Phellodendri, 14 parts of Herba Hedyotidis Diffusae, 18 parts of Semen Litchi, 26 parts of Fructus Hordei Germinatus, succinum 0.5 part, 0.5 part of Indigo Naturaliss, 0.5 part of Sanguis Draxonis.Above-mentioned raw materials are cleaned up, is brewed into decoction, quantitatively takes.Usage and dosage: mouth Clothes, two times a day, each 5ml/kg, one after each meal.
Embodiment 2
A kind of Chinese medicine treating baby's cholestasis, in parts by weight, it includes following component, 35 parts of Herba Artemisiae Scopariae, in vain 35 parts of art, 12 parts of Semen Persicae, 25 parts of Herba Lysimachiae, 25 parts of Cortex Phellodendri, 26 parts of Herba Hedyotidis Diffusae, 26 parts of Semen Litchi, 35 parts of Fructus Hordei Germinatus, succinum 1.5 parts, 1.5 parts of Indigo Naturaliss, 1.5 parts of Sanguis Draxonis.Above-mentioned raw materials are cleaned up, is brewed into decoction, quantitatively takes.Usage and dosage: mouth Clothes, two times a day, each 5ml/kg, one after each meal.
Embodiment 3
A kind of Chinese medicine treating baby's cholestasis, in parts by weight, it includes following component, 30 parts of Herba Artemisiae Scopariae, in vain 30 parts of art, 10 parts of Semen Persicae, 20 parts of Herba Lysimachiae, 20 parts of Cortex Phellodendri, 20 parts of Herba Hedyotidis Diffusae, 20 parts of Semen Litchi, 30 parts of Fructus Hordei Germinatus, succinum 1 part, 1 part of Indigo Naturaliss, 1 part of Sanguis Draxonis.Above-mentioned raw materials are cleaned up, is brewed into decoction, quantitatively takes.Usage and dosage: oral, one day Secondary, each 5ml/kg, one after each meal.
Embodiment 4
A kind of Chinese medicine treating baby's cholestasis, in parts by weight, it includes following component, 32 parts of Herba Artemisiae Scopariae, in vain 28 parts of art, 11 parts of Semen Persicae, 24 parts of Herba Lysimachiae, 17 parts of Cortex Phellodendri, 23 parts of Herba Hedyotidis Diffusae, 19 parts of Semen Litchi, 34 parts of Fructus Hordei Germinatus, succinum 0.8 part, 1.2 parts of Indigo Naturaliss, 0.9 part of Sanguis Draxonis.Above-mentioned raw materials are cleaned up, is brewed into decoction, quantitatively takes.Usage and dosage: mouth Clothes, two times a day, each 5ml/kg, one after each meal.
Embodiment 5
A kind of Chinese medicine treating baby's cholestasis it is characterised in that: in parts by weight, it includes following component, 19 parts of Herba Artemisiae Scopariae, 26 parts of the Rhizoma Atractylodis Macrocephalae, 8 parts of Semen Persicae, 19 parts of Herba Lysimachiae, 24 parts of Cortex Phellodendri, 19 parts of Herba Hedyotidis Diffusae, 25 parts of Semen Litchi, raw wheat 29 parts of bud, 1.4 parts of succinum, 0.9 part of Indigo Naturaliss, 1.3 parts of Sanguis Draxonis.Above-mentioned raw materials are cleaned up, is brewed into decoction, quantitatively takes. Usage and dosage: oral, two times a day, and each 5ml/kg, one after each meal.
Embodiment 6
A kind of Chinese medicine treating baby's cholestasis it is characterised in that: in parts by weight, it includes following component, 31 parts of Herba Artemisiae Scopariae, 31 parts of the Rhizoma Atractylodis Macrocephalae, 11 parts of Semen Persicae, 21 parts of Herba Lysimachiae, 21 parts of Cortex Phellodendri, 21 parts of Herba Hedyotidis Diffusae, 21 parts of Semen Litchi, raw wheat 31 parts of bud, 1.2 parts of succinum, 1.2 parts of Indigo Naturaliss, 1.2 parts of Sanguis Draxonis.Above-mentioned raw materials are cleaned up, is brewed into decoction, quantitatively takes. Usage and dosage: oral, two times a day, and each 5ml/kg, one after each meal.
Clinical observation on the therapeutic effect
1 clinical data: the infant that hospital neonates section of Qingdao City is met cholestasis is randomly divided into experimental group (Chinese medicine Decoction group) 50 carry out Comparison of therapeutic to observe Chinese medicine decoction of the present invention for baby's bile with matched group (Yin Zhi Huang group) 90 The curative effect of alluvial disease;The each group age is the 0-3 month;Wherein experimental group male 29, women 21, mean age (1.97 soil 0.59 month);Male 51 in matched group, women 39, the mean age (2.02 soil 1.12 months);Two groups of situation no significant difference (p > 0.05), there is comparability.
2 diagnostic criterias: " the Infantile hepatitis syndrome diagnosis and treatment rhetoric feature " worked out with reference to 2004, in conjunction with following index: 1. serum total bilirubin tbil >=85.5 μm ol/l;2. serum direct bilirubin dbil >=34.2 μm ol/l;3. stool color is Light yellow to white;4. hepatosplenomegaly >=3cm or quality change;5. alanine aminotransferase alt, glutamic oxaloacetic transaminase, GOT ast normal or Increase.
3 Therapeutic Method: experimental group uses oral Chinese medicine of the present invention, usage and dosage: oral, two times a day, each 5ml/kg; Matched group adopts Yinzhihuang oral liquid, usage and dosage: oral, 1 twice-daily, each 5ml/kg.It is within 14 days a course for the treatment of.Wherein, mattress The manufacturer of Cape jasmine Huang oral liquid is Beijing Huarun High-Tech Natural Pharmaceutical Co., Ltd..
4 curative effect determinate standards
Cure: infant xanthochromia disappears, biochemical indicator (tbil, dbil) and liver function (alt, ast) index are just recovered Often, liver spleen no enlargement.
Effective: infant xanthochromia substantially mitigates, biochemical indicator (tbil, dbil) tends to normal, liver function (alt, ast) Substantially recover, hepatosplenomegaly is obviously reduced.
Effective: the clinical symptoms of patient are obviously improved, biochemical indicator (tbil, dbil) has a certain degree of recovery, liver function Can (alt, ast) recover.
Invalid: the clinical symptoms of patient are no improved, biochemical indicator (tbil, dbil) no recovers, and liver function (alt, ast) is no Recover, the state of an illness is in gradually to increase trend.
5 the results are shown in Table 1.
Table 1 experimental group and the comparison of matched group curative effect
Note: statistics education spss17.0 statistical software, using ridit analysis, p < 0.05 represents has statistics meaning Justice.
(1) 95% credibility interval of experimental group population mean ridit value is [0.644,0.808], and two groups of differences have statistics Meaning (p < 0.05), result proves that experimental group treats the curative effect of baby's cholestasis better than matched group.
(2) this result of study confirms, rapid-action using this Chinese medicine preparation, can obviously reduce Infant with Jaundice index, and infant is treated Effect is notable, and effective percentage is 92.0%.The compliance of this Chinese medicine preparation is good, and consumption is few, instant effect, and has no toxic side effect, treats effectively Rate is high.

Claims (5)

1. a kind of Chinese medicine treating baby's cholestasis it is characterised in that: in parts by weight, it is made up of following component: Herba Artemisiae Scopariae 25-35 part, Rhizoma Atractylodis Macrocephalae 25-35 part, Semen Persicae 5-12 part, Herba Lysimachiae 15-25 part, Cortex Phellodendri 16-25 part, Herba Hedyotidis Diffusae 14-26 Part, Semen Litchi 18-26 part, Fructus Hordei Germinatus 26-35 part, succinum 0.5-1.5 part, Indigo Naturaliss 0.5-1.5 part, Sanguis Draxonis 0.5-1.5 part.
2. according to described in claim 1 treatment baby's cholestasis Chinese medicine it is characterised in that: in parts by weight, it It is made up of following component: Herba Artemisiae Scopariae 27-33 part, Rhizoma Atractylodis Macrocephalae 27-33 part, Semen Persicae 7-10 part, Herba Lysimachiae 17-23 part, Cortex Phellodendri 18-23 part, Herba Hedyotidis Diffusae 16-24 part, Semen Litchi 20-24 part, Fructus Hordei Germinatus 28-33 part, succinum 0.7-1.3 part, Indigo Naturaliss 0.7-1.3 part, blood Exhaust 0.7-1.3 part.
3. according to described in claim 1 treatment baby's cholestasis Chinese medicine it is characterised in that: in parts by weight, it It is made up of following component: Herba Artemisiae Scopariae 29-31 part, Rhizoma Atractylodis Macrocephalae 29-31 part, Semen Persicae 8-9 part, Herba Lysimachiae 19-21 part, Cortex Phellodendri 20-21 part, in vain Serpentis SHECAO 18-22 part, Semen Litchi 21-23 part, Fructus Hordei Germinatus 30-31 part, succinum 0.9-1.1 part, Indigo Naturaliss 0.9-1.1 part, Sanguis Draxonis 0.9-1.1 part.
4. according to described in claim 1 treatment baby's cholestasis Chinese medicine it is characterised in that: in parts by weight, it It is made up of following component: 30 parts of Herba Artemisiae Scopariae, 30 parts of the Rhizoma Atractylodis Macrocephalae, 10 parts of Semen Persicae, 20 parts of Herba Lysimachiae, 20 parts of Cortex Phellodendri, 20 parts of Herba Hedyotidis Diffusae, 20 parts of Semen Litchi, 30 parts of Fructus Hordei Germinatus, 1 part of succinum, 1 part of Indigo Naturaliss, 1 part of Sanguis Draxonis.
5. according to claim 1-4 any one treatment baby's cholestasis Chinese medicine it is characterised in that: in described Medicine is decoction.
CN201410159431.2A 2014-04-21 2014-04-21 Traditional Chinese medicine for treating infantile cholestasis Expired - Fee Related CN103893634B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410159431.2A CN103893634B (en) 2014-04-21 2014-04-21 Traditional Chinese medicine for treating infantile cholestasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410159431.2A CN103893634B (en) 2014-04-21 2014-04-21 Traditional Chinese medicine for treating infantile cholestasis

Publications (2)

Publication Number Publication Date
CN103893634A CN103893634A (en) 2014-07-02
CN103893634B true CN103893634B (en) 2017-01-18

Family

ID=50985418

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410159431.2A Expired - Fee Related CN103893634B (en) 2014-04-21 2014-04-21 Traditional Chinese medicine for treating infantile cholestasis

Country Status (1)

Country Link
CN (1) CN103893634B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104288691A (en) * 2014-10-20 2015-01-21 济南高达信息技术有限公司 Traditional Chinese medicine decoction for treating cholestasis syndrome
CN107837307A (en) * 2017-11-13 2018-03-27 鄢素琪 A kind of Chinese medicine cholagogic composition for treating baby's cholestasis and purposes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
1月龄婴儿黄疸持续不退;王建设等;《中国循证儿科杂志》;20080930;第3卷(第5期);388-396 *
成秋宸等.荔枝核总黄酮对胆汁淤积性肝纤维化大鼠抗肝纤维化的机制探讨.《医药论坛杂志》.2013,第34卷(第12期),11-14. *
胡艳等.裴学义治疗婴儿肝炎综合症经验.《中国中医药信息杂志》.2012,第19卷(第2期),87. *
裴学义教授治疗难治型乳儿黄疸一则;孙淑芬等;《北京中医药大学学报》;19990930;第22卷(第5期);79 *

Also Published As

Publication number Publication date
CN103893634A (en) 2014-07-02

Similar Documents

Publication Publication Date Title
CN1562160A (en) Composite medicine for treating hepatitis B complication
CN103861046B (en) One treats prosopalgic Chinese medicine
CN104523865A (en) Medicine for treating breast diseases
CN101537060A (en) Medicine for treating AIDS
CN103920074A (en) Traditional Chinese medicine composition for treating hepatitis B
CN103893634B (en) Traditional Chinese medicine for treating infantile cholestasis
CN104116971B (en) Traditional Chinese medicine composition for treating liver disease pruritus and preparation method thereof
CN103845429A (en) Traditional Chinese medicine for treating chronic hepatitis
CN105012485A (en) Traditional Chinese medicine granule for treating neonatal jaundice
CN104547736A (en) Medicine for treating goiter
CN103816486B (en) A kind of Chinese medicine preparation for the treatment of acute, chronic hepatitis
CN102166311B (en) Preparation method of Chinese medicine for treating spleen-deficiency sthenic liver-energy hyperthyroidism
CN110946950A (en) A Chinese medicinal composition for treating senile vascular dementia, and its preparation method
CN104147270A (en) Traditional Chinese medicine for treating acute hepatitis
CN1077437C (en) Chinese patent medicine for treating prostatic diseases
CN110787237B (en) Traditional Chinese medicine composition for effectively treating gastrocnemius spasm and preparation method and application thereof
CN102423354A (en) Traditional Chinese medicine for treating hypertension
CN102743595B (en) Preparation method of Chinese medicine irrigation solution for treating kidney-yin deficiency type trichomonas vaginitis
CN105561001A (en) Traditional Chinese medicine composition for treating alcoholic hepatitis
CN103610855A (en) Traditional Chinese medicine composition for treating children obesity
CN111558020A (en) Medicine for treating liver cirrhosis
CN103316258B (en) Medicine composition for treating infantile vaginitis
CN103463375A (en) Traditional Chinese medicine composition for treating chronic type viral hepatitis B
CN103432409B (en) A kind for the treatment of is addicted to the Chinese medicine of food barbecue type axilla acute suppurative lymphadenitis
CN110917328A (en) Application of bupleuri radix, keel and oyster soup and Hua-Chao-Ku-Ge-Tang in preparation of medicine for treating anhidrosis-type hand-foot-and-mouth disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170118

Termination date: 20170421

CF01 Termination of patent right due to non-payment of annual fee